Robert Beardsley is an Ophthalmology physician affiliated with Minnesota Eye Consultants. OpenAlex indexes 19 publications with 429 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1550 Oak St
Suite 7
Eugene, OR 974017701
Telephone
541-687-1927Registry record last updated 6 Apr 2017.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RxSight IncProgram year20251 payment
- ABBVIE INC.Program year20254 payments
- Regeneron Healthcare Solutions, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
80.4%Antineovascularisation agents76.6%Faricimab-svoa100%Part B, office-administered≥103 patientsComplement Inhibitor1.7%Avacincaptad pegol100%Part B, office-administered≥12 patients+ 9 more classes in this area
Cancer & immunology
19%Complement Inhibitor13%Pegcetacoplan100%Part B, office-administered≥72 patientsVascular Endothelial Growth Factor Inhibitor6%Aflibercept100%Part B, office-administered≥277 patients+ 1 more class in this area
Musculoskeletal
0.2%Cyclooxygenase Inhibitor0.2%Ketorolac Tromethamine100%Part D≥49 patientsNonsteroidal Anti-inflammatory Drug0%Diclofenac Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 25 vs. 27-gauge micro-incision vitrectomy surgery for visually significant macular membranes and full-thickness macular holes: a retrospective study
International Journal of Retina and Vitreous
2020 - Comparison of outcomes of 25-gauge vs 27-gauge micro-incision vitrectomy surgery for visually significant macular membranes and full-thickness macular holes
Investigative Ophthalmology & Visual Science
2020 - Strategies for Improving Patient Comfort During Intravitreal Injections: Results from a Survey-Based Study
Ophthalmology and Therapy
2016 - Early Recognition of and Intervention for Susac Syndrome in a Teenager With Encephalopathy
Arthritis & Rheumatology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Jacob Brubaker, MD
Minnesota Eye Consultants
Sara Haug, MD, PhD
Minnesota Eye Consultants
Allan Hunter, MD
Minnesota Eye Consultants
Peter Karth, MD
Minnesota Eye Consultants
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”